The Effect of Intra-operative Ketorolac on Hematoma Rates in Breast Reduction Surgery
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
It has been a longstanding teaching in plastic surgery that intra-operative ketorolac use for
postoperative pain control increases hematoma and bleeding in breast reduction surgery.
However, there is no literature that supports this teaching. Ketorolac is used routinely in
free flap reconstruction including breast reconstruction as well as many other surgeries
including hand surgery without increased risks of hematoma or bleeding. Ketorolac has been
shown to give good postoperative pain control. The object of this study is to look at whether
ketorolac increases the rate of hematoma/bleeding in breast reduction. If there is no
increased risk of hematoma, then ketorolac can be used safely for postoperative pain control
with an increased risk of hematoma/bleeding. Normally, without using ketorolac, the hematoma
rates in a breast reduction are 1-2%.